Sermorelin
A GHRH(1-29) analog studied for pituitary growth-hormone stimulation.
Research Overview
Sermorelin corresponds to the first 29 amino acids of growth-hormone-releasing hormone — the minimal fully active GHRH fragment. It is studied as a GHRH-receptor agonist that stimulates endogenous growth-hormone synthesis and release from the anterior pituitary.
As a GHRH analog it is a common reference tool in GH-axis and pituitary-secretion research.
Specifications
| Compound | Sermorelin (GRF 1-29) |
| Classification | Endocrine research compound |
| Molecular weight | 3,357.9 g/mol |
| Sequence / Form | GHRH(1-29) |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
